Journals / Balkan Medical Journal / 2018 / Cilt: 35 - Sayı: 6

Can NT-pro BNP Levels Predict Prognosis of Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease in the Intensive Care Unit?

Pages
422–426
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The mortality rate wassignificantly higher in patients who had an increasing trend of aminoterminal pro-brain natriuretic peptide levels during hospitalizationthan in patients who had decreasing levels (59% vs. 23%, p=0.015).Based on the receiver operating characteristic analysis, the increasingtrend of amino terminal pro-brain natriuretic peptide levels duringintensive care unit stay predicted mortality with area under curveof 0.84 (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: The prognostic value of amino terminal pro-brainnatriuretic peptide levels in patients with acute exacerbation ofchronic obstructive pulmonary disease has not been fully established.Aims: To investigate the predictive value of amino terminal pro-brainnatriuretic peptide levels in terms of mortality, need for noninvasivemechanical ventilation, invasive mechanical ventilation, and weaningsuccess.Study Design: Cohort study.Methods: Patients who were admitted to intensive care unit betweenDecember 2015 and December 2016 due to acute exacerbation ofchronic obstructive pulmonary disease were included in the study.Demographic data, noninvasive mechanical ventilation application,need for invasive mechanical ventilation, amino terminal pro-brainnatriuretic peptide level, duration of mechanical ventilation, intensivecare unit and hospital stay, weaning success, and mortality rates wererecorded.Results: A total of 110 patients (75 males) were included in the study.The mean age of the participants was 69 (61-76) years, and the meanAcute Physiology and Chronic Health Evaluation II score was 19 (15-23).
📊
Key Findings & Data:The mean amino terminal pro-brain natriuretic peptide level wasfound to be lower in cases with noninvasive mechanical ventilationsuccess than those with noninvasive mechanical ventilation failure(p=0.053).
💡
Conclusion & Impact:The mortality rate wassignificantly higher in patients who had an increasing trend of aminoterminal pro-brain natriuretic peptide levels during hospitalizationthan in patients who had decreasing levels (59% vs. 23%, p=0.015).Based on the receiver operating characteristic analysis, the increasingtrend of amino terminal pro-brain natriuretic peptide levels duringintensive care unit stay predicted mortality with area under curveof 0.84 (p
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Background: The prognostic value of amino terminal pro-brainnatriuretic peptide levels in patients with acute exacerbation ofchronic obstructive pulmonary disease has not been fully established.Aims: To investigate the predictive value of amino terminal pro-brainnatriuretic peptide levels in terms of mortality, need for noninvasivemechanical ventilation, invasive mechanical ventilation, and weaningsuccess.Study Design: Cohort study.Methods: Patients who were admitted to intensive care unit betweenDecember 2015 and December 2016 due to acute exacerbation ofchronic obstructive pulmonary disease were included in the study.Demographic data, noninvasive mechanical ventilation application,need for invasive mechanical ventilation, amino terminal pro-brainnatriuretic peptide level, duration of mechanical ventilation, intensivecare unit and hospital stay, weaning success, and mortality rates wererecorded.Results: A total of 110 patients (75 males) were included in the study.The mean age of the participants was 69 (61-76) years, and the meanAcute Physiology and Chronic Health Evaluation II score was 19 (15-23). The mean amino terminal pro-brain natriuretic peptide level wasfound to be lower in cases with noninvasive mechanical ventilationsuccess than those with noninvasive mechanical ventilation failure(p=0.053). In addition, the mean amino terminal pro-brain natriureticpeptide level was significantly higher (4740 pg/mL vs. 3004 pg/mL,p=0.001) in patients who needed invasive mechanical ventilationsupport than in patients who did not. The mortality rate wassignificantly higher in patients who had an increasing trend of aminoterminal pro-brain natriuretic peptide levels during hospitalizationthan in patients who had decreasing levels (59% vs. 23%, p=0.015).Based on the receiver operating characteristic analysis, the increasingtrend of amino terminal pro-brain natriuretic peptide levels duringintensive care unit stay predicted mortality with area under curveof 0.84 (p

🔖

Cite This Article

KIRAKLI, C., EDİBOĞLU, Ö. (2022). Can NT-pro BNP Levels Predict Prognosis of Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease in the Intensive Care Unit?. Balkan Medical Journal, Cilt: 35 - Sayı: 6, 422–426. https://ajindex.com/articles/461092

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Diseases (GOLD) 2017
  2. Pan W, Yu J, Zhang L, Yang H, Yuan Y. Predictors of in-hospital mortality in patients with acute exacerbation of COPD requiring ventilation: a retrospective study. Int J Clin Exp Med 2016;9:22093-22101
  3. Marcun R, Sustic A, Brguljan PM, Kadivec S, Farkas J, Kosnik M, et al. Cardiac biomarkers predict outcome after hospitalisation for an acute exacerbation of chronic obstructive pulmonary disease. Int J Cardiol 2012;161:156-9
  4. Chang CL, Robinson SC, Mills GD, Sullivan GD, Karalus NC, McLachlan JD, et al. Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD. Thorax 2011;66:764-8
  5. Pavasini R, Tavazzi G, Biscaglia S, Guerra F, Pecoraro A, Zaraket F, et al. Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis. Chron Respir Dis 2017;14:117-26
  6. Bar SL, Swiggum E, Straatman L, Ignaszewski A. Nonheart failure-associated elevation of amino terminal pro-brain natriuretic peptide in the setting of sepsis. Can J Cardiol 2006;22:263-6
  7. Hawkins NM, Khosla A, Virani SA, McMurray JJ, FitzGerald JM. B-type natriuretic peptides in chronic obstructive pulmonary disease: a systematic review. BMC Pulm Med 2017;17:11
  8. Boles JM, Bion J, Connors A, Herridge M, Marsh M, Melot C, et al. Weaning from mechanical ventilation. Eur Respir J 2007;29:1033-56
  9. Niewoehner DE, Lokhnygina Y, Rice K, Kuschner WG, Sharafkhaneh A, Sarosi GA, et al. Risk indexes for exacerbations and hospitalizations due to COPD. Chest 2007;131:20-8
  10. Garcia-Aymerich J, Monso E, Marrades RM, Escarrabill J, Félez MA, Sunyer J, et al. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study. Am J Respir Crit Care Med 2001;164:1002-7
  11. Inoue Y, Kawayama T, Iwanaga T, Aizawa H. High Plasma Brain Natriuretic Peptide Levels in Stable COPD without Pulmonary Hypertension or Cor Pulmonale. Intern Med 2009;48:503-12
  12. Budweiser S, Luchner A, Jörres RA, Heinemann F, Hitzl AP, Schmidbauer K, et al. NT-pro BNP in chronic hypercapnic respiratory failure: a marker of disease severity, treatment effect and prognosis. Respir Med 2007;101:2003-10
  13. Stolz D, Breidthardt T, Christ-Crain M, Bingisser R, Miedinger D, Leuppi J, et al. Use of B-type natriuretic peptide